Historique
Rapport
Strategies and coordination in the field of drugs in the European Union: a descriptive review
Auteur(s) :
BALLOTTA, D. ;
D'ARRIGO L. ;
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année
2002
Page(s) :
184 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
Domaine :
Drogues illicites / Illicit drugs
Discipline :
SAN (Santé publique / Public health)
Thésaurus mots-clés
PROGRAMME
;
POLITIQUE
;
DEFINITION
;
COMPARAISON
Thésaurus géographique
UNION EUROPEENNE
;
NORVEGE
Organismes
OEDT
Note générale :
Lisbonne, EMCDDA, 2002, 184 p.
Résumé :
ENGLISH :
The aim of this report is to provide a descriptive and comparative review of the national drug strategies, action plans and coordination mechanisms adopted in the European Union, largely since the end of the 90s. In addressing this study we have tried to answer to the following questions: Do all EU countries have a written, definable drug strategy/action plan? What are the main elements and objectives of this document? Is there a new trend in drug policy, at least as far as official declarations are concerned? How do countries coordinate the multifaceted issue of drugs? Do all countries have coordination agencies, and coordinators, or merely coordination systems?
Our objective is to:
1. provide the European Union with a reliable information source upon which to base a broader reflection on European drug strategies and related coordination issues, as requested by the EU Action Plan on Drugs 2000 - 2004;
2. offer national drug coordinators, responsible for drug coordination in the EU Member States and professionals in the field a reliable and objective pan-European picture of trends in drug strategies; and
3. establish a baseline of national drug strategies, action plans and coordination mechanisms in the field of drugs in the EU which, constantly monitored and updated, will hopefully contribute to evaluate the EU Action Plan on Drugs (2000-2004).
The study is divided into two sections. The first, addresses issues such as semantic problems and definitions and new attitudes in drug policy. It includes a systematic comparative overview of the main elements of national drug strategies and closes with a comparative description of drug coordination arrangements. The second section offers individual country profiles, structured in such a way as to present national drug strategies, action plans and coordination across countries in a systematic, uniform way. (Extract of the publication)
The aim of this report is to provide a descriptive and comparative review of the national drug strategies, action plans and coordination mechanisms adopted in the European Union, largely since the end of the 90s. In addressing this study we have tried to answer to the following questions: Do all EU countries have a written, definable drug strategy/action plan? What are the main elements and objectives of this document? Is there a new trend in drug policy, at least as far as official declarations are concerned? How do countries coordinate the multifaceted issue of drugs? Do all countries have coordination agencies, and coordinators, or merely coordination systems?
Our objective is to:
1. provide the European Union with a reliable information source upon which to base a broader reflection on European drug strategies and related coordination issues, as requested by the EU Action Plan on Drugs 2000 - 2004;
2. offer national drug coordinators, responsible for drug coordination in the EU Member States and professionals in the field a reliable and objective pan-European picture of trends in drug strategies; and
3. establish a baseline of national drug strategies, action plans and coordination mechanisms in the field of drugs in the EU which, constantly monitored and updated, will hopefully contribute to evaluate the EU Action Plan on Drugs (2000-2004).
The study is divided into two sections. The first, addresses issues such as semantic problems and definitions and new attitudes in drug policy. It includes a systematic comparative overview of the main elements of national drug strategies and closes with a comparative description of drug coordination arrangements. The second section offers individual country profiles, structured in such a way as to present national drug strategies, action plans and coordination across countries in a systematic, uniform way. (Extract of the publication)
Affiliation :
Portugal